These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8215712

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition by WEB 2086, a PAG-acether antagonist of oedema and peritonitis induced by zymosan in rats.
    Damas J, Remacle-Volon G, Nguyen TP.
    Arch Int Pharmacodyn Ther; 1990; 306():161-9. PubMed ID: 2076045
    [Abstract] [Full Text] [Related]

  • 3. Production of platelet-activating factor in inflammatory exudate.
    Oh-ishi S, Imai Y, Hayashi M.
    J Lipid Mediat; 1992; 5(2):115-20. PubMed ID: 1525350
    [Abstract] [Full Text] [Related]

  • 4. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
    Zhang F, Decker K.
    Eur Cytokine Netw; 1994; 5(3):311-7. PubMed ID: 7948767
    [Abstract] [Full Text] [Related]

  • 5. Involvement of platelet-activating factor in zymosan-induced rat pleurisy.
    Imai Y, Hayashi M, Oh-ishi S.
    Lipids; 1991 Dec; 26(12):1408-11. PubMed ID: 1819742
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M, Nishioka E, Kanoh R, Tachibana M, Fukuishi N.
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC, Seldon PM, Barnes PJ, Giembycz MA.
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of the antagonist activity of the PAF antagonists RP 59227 and WEB 2086 on elicited guinea pig peritoneal macrophages. Evidence for variable affinities and kinetics.
    Turner NC, Wood LJ.
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1139-46. PubMed ID: 1326625
    [Abstract] [Full Text] [Related]

  • 14. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
    Issekutz AC, Szpejda M.
    Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
    [Abstract] [Full Text] [Related]

  • 15. Platelet-activating factor and the vascular effects of zymosan in rats.
    Damas J, Remacle-Volon G, Bourdon V.
    Eur J Pharmacol; 1993 Feb 09; 231(2):231-6. PubMed ID: 8453979
    [Abstract] [Full Text] [Related]

  • 16. Resident peritoneal leukocytes are important sources of MMP-9 during zymosan peritonitis: superior contribution of macrophages over mast cells.
    Kolaczkowska E, Lelito M, Kozakiewicz E, van Rooijen N, Plytycz B, Arnold B.
    Immunol Lett; 2007 Nov 15; 113(2):99-106. PubMed ID: 17826846
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.
    Martins MA, Silva PM, Faria Neto HC, Bozza PT, Dias PM, Lima MC, Cordeiro RS, Vargaftig BB.
    Br J Pharmacol; 1989 Feb 15; 96(2):363-71. PubMed ID: 2924083
    [Abstract] [Full Text] [Related]

  • 19. Key role of complement activation and platelet-activating factor in exudate formation in zymosan-induced rat pleurisy.
    Imai Y, Hayashi M, Oh-ishi S.
    Jpn J Pharmacol; 1991 Oct 15; 57(2):225-32. PubMed ID: 1812301
    [Abstract] [Full Text] [Related]

  • 20. Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes.
    Chávez-Cartaya RE, Metcalfe S, Ramirez-Romero P, Calne R, Jamieson NV.
    Transplantation; 1994 May 27; 57(10):1440-4. PubMed ID: 8197604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.